Oleh B. Dynnyk

Oleh B. Dynnyk

Auto-generated profile, based on publicly available information

Oleh B. Dynnyk

Bogomolets Institute of physiology of the Ukrainian National Academy of Sciences, Kyiv, Ukraine

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2018 in Journal of Gastrointestinal and Liver Diseases
Verified
Journal Article
Closed access
NKNazarii Kobyliak
Nazarii Kobyliak
LALudovico Abenavoli
Ludovico Abenavoli
GMGalyna Mykhalchyshyn
Galyna Mykhalchyshyn
LKLiudmyla Kononenko
Liudmyla Kononenko
LBLuigi Boccuto
Luigi Boccuto
ODOleg Dynnyk
Oleg Dynnyk
Background: Probiotics have a beneficial effect on nonalcoholic fatty liver disease (NAFLD) in animal models. Randomized placebo-controlled trials (RCTs) in NAFLD are still lacking in humans despite a large number of data from animal research.Aim: We performed a double-blind single center RCT of live multi-strain probiotic vs. placebo in type 2 diabetes patients with NAFLD.Methods: A total of 58 patients met the criteria for inclusion. They were randomly assigned to receive the multiprobiotic “Symbiter” (concentrated biomass of 14 probiotic bacteria genera Bifidobacterium, Lactobacillus, Lactococcus, Propionibacterium) or placebo for 8-weeks administered as a sachet formulation in double-blind treatment. The primary main outcomes were the changes in fatty liver index (FLI) and liver stiffness (LS) measured by Shear Wave Elastography (SWE). Secondary outcomes were the changes in aminotransferase activity, serum lipids and cytokines (TNF-α, IL-1β, IL-6, IL-8, and IFN-γ) levels. Analysis of covariance was used to assess the difference between groups.Results: In the probiotic group, FLI significantly decreased from 84.33±2.23 to 78.73±2.58 (p<0.001) but it did not change in the placebo group (82.57±2.45 to 81.6 ±2.36; p=0.367). In both groups a slight but not significant reduction of LS measured by SWE was detected. Analysis of the secondary outcomes showed that probiotics reduced the level of serum AST and GGT. Among the markers of chronic systemic inflammatory state, only TNF-α and IL-6 levels changed significantly after the treatment with the probiotic.Conclusion: The probiotic “Symbiter” reduces liver fat, aminotransferase activity, and the TNF-α and IL-6 levels in NAFLD patients. Modulation of the gut microbiota might represent a new therapy for NAFLD, which should be tested in larger studies.

1 December 2018 in Minerva Medica
Verified
Journal Article
Closed access
NKNazarii Kobyliak
Nazarii Kobyliak
LALudovico Abenavoli
Ludovico Abenavoli
TFTetyana Falalyeyeva
Tetyana Falalyeyeva
GMGalyna Mykhalchyshyn
Galyna Mykhalchyshyn
LBLuigi Boccuto
Luigi Boccuto
ODOleg Dynnyk
Oleg Dynnyk
The manipulation of gut microbiota via administration of probiotics has been proposed as a potential strategy for the treatment of non-alcoholic fatty liver disease (NAFLD). Hence, we performed a double-blind single center randomized placebo-controlled trial (RCT) to evaluate the efficacy of coadministration of probiotics with omega-3 vs. placebo in type-2 diabetic patients with NAFLD. A total of 48 patients met the criteria for inclusion. They were randomly assigned to receive "Symbiter Omega" combination of probiotic biomass supplemented with flax and wheat germ oil (250 mg of each, concentration of omega-3 fatty acids 1-5%) or placebo for 8-weeks. The primary main outcomes were the change in fatty liver index (FLI) and liver stiffness (LS) measured by Shear Wave Elastography (SWE). Secondary outcomes were the changes in transaminases level, serum lipids and cytokines levels. In probiotic-omega group, FLI significantly decreased from 83.53±2.60 to 76.26±2.96 (P<0.001) while no significant changes were observed in the placebo group (82.86±2.45 to 81.09±2.84; P=0.156). Changes of LS in both groups were insignificant. Analysis of secondary outcomes showed that the coadministration of probiotics with omega-3 lead to significant reduction of serum gamma-glutamyl transpeptidase, triglycerides, and total cholesterol. Chronic systemic inflammatory markers after intervention decrease significantly only in Symbiter Omega group: IL-1β (P=0.029), TNF-α (P<0.001), IL-8 (P=0.029), IL-6 (P=0.003), and INF-γ (P=0.016). Coadministration of a live multi-strain probiotic mixture with omega-3 fatty acids once daily for 8 weeks to patients with NAFLD can reduce liver fat, improve serum lipids, metabolic profile, and reduce chronic systemic inflammatory state.

4 October 2023 in Heliyon
Verified
Journal Article
Open access
NKNazarii Kobyliak
Nazarii Kobyliak
ODOleh Dynnyk
Oleh Dynnyk
MSMaryana Savytska
Maryana Savytska
OSOleksandr Solodovnyk
Oleksandr Solodovnyk
OZOleksandr Zakomornyi
Oleksandr Zakomornyi
RTRoman Titorenko
Roman Titorenko
To evaluate the accuracy and reproducibility of real time ultrasound (US) steatometry with the Attenuation Coefficient (AC) measurement in comparison with magnetic resonance imaging with proton density software module (MRI-PDFF). This study was conducted between January 2021 and October 2021. The comparison of instrumental methods for assessing and grading hepatic steatosis using a multimodal phantom simulator of different fat and water ratios was performed. The study involved 3 radiological centers. The steatophantom was simultaneously investigated using three methods: magnetic resonance imaging with proton density software module (MRI-PDFF) and 128-slice multidetector computed tomography, and then by 2 different US scanner for steatosis assessment via Measurement Attenuation Imaging (ATI) ant Attenuation Coefficient Measurement (ACM). Modeling of hepatic steatosis using a series of phantom simulators allows evidence-based medicine to determine the diagnostic accuracy of the latest US techniques for steatosis. The ACM and ATI of both US systems on phantoms correlated well with each other and with MRI-PDFF and, thus, can provide good diagnostic value in the assessment of hepatic steatosis. MDCT was less sensitive to mild steatosis than AC and MRI-PDFF. Measurement of ACs in US studies by devices from different vendors compared to other modalities of radiological imaging (MDCT and MRI-PDFF) by special phantoms is an accurate and promising method for noninvasive quantification of hepatic steatosis.

29 June 2021 in Infusion & Chemotherapy
Verified
Journal Article
Open access
PDF file
OSO.M. Safonova
O.M. Safonova
ODO.B. Dynnyk
O.B. Dynnyk
GGG.L. Gumeniuk
G.L. Gumeniuk
VLVitalii Lukiianchuk
Vitalii Lukiianchuk
HLH.V. Linska
H.V. Linska
SSS.O. Soliaryk
S.O. Soliaryk
BACKGROUND. The era of coronavirus disease (COVID-19) set the such task for lung ultrasound (LUS): to identify the presence of COVID-pneumonia, its differential diagnosis with other conditions which characterized by interstitial edema, determining the severity of lung damage and its location, the dynamics of pulmonary changes tissue, the development of complications, as well as to assess the effectiveness of personalized therapy. OBJECTIVE. To develop a national LUS protocol for COVID-19 based on a balance of completeness of information with the optimal minimum of time and effort for medical staff, who often do not specialize in ultrasound using, with ultrasound equipment of basic and middle classes. MATERIALS AND METHODS. A total of 1576 patients with COVID-19 were examined. There were 810 women (51.4 %) and 766 men (48.6 %). The age of the examined patients was in the range of 18-83 years, the average age was 52.3±14.6 years. 4710 LUS were performed, of which 1572 were repeated and 3144 – in the dynamics. Polysystemic ultrasound was performed in 275 patients. Ultrasound devices of both domestic and foreign production were used: Soneus P7 (Ultrasine, Ukraine), HandyUsound (Ukraine), Xario, USAP-770A (Toshiba, Japan), GE Venue (General Electric, USA) and TE7 COVID (Mindray, China) with ultrasound probes of convex, linear and microconvex formats. RESULTS. Summarizing our own experience with patients with COVID-19 in 2020-2021, we have developed a version of the LUS-protocol, which has a convenient form of recording all stages of ultrasound with maximum coverage of the entire volume of both lungs according to a clear algorithm, a graphical form, clear ultrasound semiotics and diagnostic scoring criteria for the severity of lung damage. CONCLUSIONS. 1. Clinical data indicate the feasibility and effectiveness of using LUS for dynamic monitoring of patients with pneumonia caused by SARS-CoV-2, especially in oxygen-dependent patients at their bedside (POCUS principle). 2. Optimization of the use of radiological diagnostic methods due to ultrasound makes it possible to reduce the radiation dose of the patient.3. The use of LUS allows more adequate decision-making on the need for intensive and interventional therapy, leads to faster diagnosis, improved medical care, reduced length of stay of patients in ICU, as well as reducing the total cost of treatment.4. Ability to reduce the impact of SARS-CoV-2 on healthcare professionals by limiting physical contact with the patient. 5. The standardized Ukrainian protocol of LUS provides availability, efficiency and clear interpretation of the received data at its use by different doctors in different medical institutions. The integration of the protocol in to the ultrasound machine provides optimization of the workflow process.

16 August 2019 in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
Verified
Journal Article
Open access
PDF file
ОDО.B. Dynnyk
О.B. Dynnyk
NMN.A. Marunchyn
N.A. Marunchyn
SMS.YE. Mostovy
S.YE. Mostovy
В обзоре литературы раскрыто понятие поражения эндотелия как патологии, которая является проявлением неинфекционных заболеваний ХХІ века и предиктором сердечно-сосудистых и цереброваскулярных событий, особенно у больных сахарным диабетом 2-го типа. Микроциркуляторное русло представляет собой совокупность самых мелких кровеносных сосудов (артериол, пре- и посткапиллярных сфинктеров, капилляров, венул), лимфатических капилляров, что подтверждает концепцию мультимодальности сосудисто-паренхиматозной коммуникации. Во время развития патологического процесса (болезнь, стресс) происходит высвобождение провоспалительных цитокинов, которые вызывают клеточную дисфункцию, тромбоз, фиброз и поражение эндотелия. Современным неинвазивным методом первичной оценки состояния микроциркуляции, выявления нарушений эндотелия, доказуемости эффективности влияния фармакологических препаратов, прогнозирования течения заболевания в клинической практике является лазерная допплеровская флоуметрия (ЛДФ). На основании анализа объективных параметров ЛДФ согласно европейским рекомендациям устанавливается тип кровотока (нормотонический, гиперемический, спастический, застойно-стазический) и, соответственно, факторы поражения эндотелия пациента. Не менее важным вопросом являются способы коррекции нарушений микроциркуляции (по большей части — инфузионная терапия), так как именно влияние препаратов на пре- и посткапиллярные сфинктеры позволяет установить эффективность/неэффективность проведенной терапии. ЛДФ используется в разных клинических направлениях, таких как кардиология, эндокринология, ревматология, а также как метод диагностики состояния микроциркуляторного русла в хирургической практике.

3 October 2022 in Україна. Здоров’я нації
Verified
Journal Article
Open access
PDF file
ВБВолодимир Михайлович Богомаз
Володимир Михайлович Богомаз
ОДОлег Борисович Динник
Олег Борисович Динник
НЗНаталія Юріївна Зюзь
Наталія Юріївна Зюзь
Мета дослідження: актуалізація чинників забезпечення якості роботи лікаря УЗД та їх оцінка практичними лікарями.Матеріали та методи. Дослідження виконано у 2023 році методом анонімного електронного опитування лікарів ультразвукової діагностики (УЗД) за спеціально розробленою анкетою. Анкета містила 18 відкритих і закритих запитань стосовно різних виробничих аспектів медичної практики.Результати. Актуалізовано рейтинг чинників забезпечення якості роботи за оцінками лікарів УЗД. Обговорено проблеми менеджменту якості в діагностичних підрозділах закладів охорони здоров’я.Висновки. Сучасне устаткування та можливість відвідувати навчальні заходи віднесені лікарями до найважливіших чинників, а вік лікаря отримав найнижчу оцінку серед запропонованих чинників надання якісної медичної допомоги.Ключові слова: якість медичної допомоги, ультрасонографія, опитування лікарів, POCUS.